Selected References: Carmichael SL, et.al. 2005. Maternal progestin intake and risk of hypospadias. Archives of Pediatrics & Adolescent Medicine, 159(10):957-962. Check JH, et al. 1986. The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil Steril, 45:575-577. Committee on Drugs. 2001. The transfer of drugs and other chemicals into human milk. Pediatrics, 108(3):776-789. American College of Obstetricians and Gynecologists’ Committee on Practice …
El Blog del Bebé
Acerca de Nuestro Baby Blog
Cada persona quiere saber qué es lo mejor para su bebé, especialmente cuando se trata de saber cómo minimizar los riesgos de exposición. Nuestras historias cercanas están repletas de información práctica de nuestro personal rotativo de blogueros expertos de MotherToBaby. Cualquiera que sea el tema que esté buscando, nuestros blogs le proporcionarán una gran base para obtener más información.
Lysergic Acid Diethylamide (LSD)
Selected References: Aase JM, et al. 1970. Children of mothers who took LSD in pregnancy. Lancet 1:100-1. Baquiran M, et al. 2023. Lysergic acid diethylamide toxicity. [Updated 2023 Dec 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553216/ Cohen MM, et al. 1968. The effect of LSD-25 on the chromosomes of children exposed in utero. Pediat Res 2:486-492. Das, Saibal et al. Lysergic acid diethylamide: …
Abatacept (Orencia®)
Selected References Bristol-Myers Squibb. 2019. Available at https://clinicaltrials.gov/ct2/show/record/NCT01087125?view=record Dernoncourt A, et al. 2023. Fetal and neonatal adverse drug reactions associated with biologics taken during pregnancy by women with autoimmune diseases: Insights from an analysis of the World Health Organization pharmacovigilance database (VigiBase®). BioDrugs, 37(1):73-87. E.R. Squibb and Sons, L.L.C. (Last updated: October 30, 2023). Orencia drug label. …
Omeprazole | Esomeprazole
Selected References: Ali, R, et al. 2022. Review of recent evidence on the management of heartburn in pregnant and breastfeeding women. BMC gastroenterology; 22.1: 1-10. Anderka M, et al. 2012. National Birth Defects Prevention Study. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol; 94:22-30. Andersen ABT, et al. 2012. Prenatal exposure to acid-suppressive drugs and the risk of toddler asthma: a …
Famotidine
Selected References: Affendi Raja RA, et al. 2022. Review of recent evidence on the management of heartburn in pregnant and breastfeeding women. BMC Gastroenterology, 22:219-229. Courtney TP, et al. 1988. Excretion of famotidine in breast milk. Br J Clin Pharmacol, 626:639P. Garbis H, et al. 2005. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol, 19:453-458. …
